Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 84

Similar articles for PubMed (Select 24524064)

1.

The necessity of bone densitometry for patients taking selective serotonin reuptake inhibitors.

An KY, Shin WJ, Lee KJ.

J Bone Metab. 2013 Nov;20(2):95-8. doi: 10.11005/jbm.2013.20.2.95. Epub 2013 Nov 18.

2.

Calcaneal bone mineral density in young adults prescribed selective serotonin reuptake inhibitors.

Seifert CF, Wiltrout TR.

Clin Ther. 2013 Sep;35(9):1412-7. doi: 10.1016/j.clinthera.2013.07.423. Epub 2013 Aug 16.

PMID:
23958172
3.

[Selective serotonin reuptake inhibitors (SSRI) and osteoporosis].

Fétique-Will AC, Chevalley T, Rizzoli R.

Rev Med Suisse. 2011 Jun 15;7(299):1299-304. French.

PMID:
21793419
4.

Selective serotonin reuptake inhibitor treatment and depression are associated with poststroke mortality.

Ried LD, Jia H, Feng H, Cameon R, Wang X, Tueth M, Wu SS.

Ann Pharmacother. 2011 Jul;45(7-8):888-97. doi: 10.1345/aph.1P478. Epub 2011 Jul 12.

PMID:
21750310
5.

Association of low bone mineral density with selective serotonin reuptake inhibitor use by older men.

Haney EM, Chan BK, Diem SJ, Ensrud KE, Cauley JA, Barrett-Connor E, Orwoll E, Bliziotes MM; Osteoporotic Fractures in Men Study Group.

Arch Intern Med. 2007 Jun 25;167(12):1246-51.

PMID:
17592097
6.

Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2006;6(20):1-180. Epub 2006 Nov 1.

7.

Effect of selective serotonin reuptake inhibitors on the risk of fracture.

Richards JB, Papaioannou A, Adachi JD, Joseph L, Whitson HE, Prior JC, Goltzman D; Canadian Multicentre Osteoporosis Study Research Group.

Arch Intern Med. 2007 Jan 22;167(2):188-94.

PMID:
17242321
8.
9.

Selective serotonin reuptake inhibitors, glioblastoma multiforme, and impact on toxicities and overall survival: the mayo clinic experience.

Caudill JS, Brown PD, Cerhan JH, Rummans TA.

Am J Clin Oncol. 2011 Aug;34(4):385-7. doi: 10.1097/COC.0b013e3181e8461a.

PMID:
20859197
10.

Economic impact of therapeutic substitution of a brand selective serotonin reuptake inhibitor with an alternative generic selective serotonin reuptake inhibitor in patients with major depressive disorder.

Wu EQ, Yu AP, Lauzon V, Ramakrishnan K, Marynchenko M, Ben-Hamadi R, Blum S, Erder MH.

Ann Pharmacother. 2011 Apr;45(4):441-51. doi: 10.1345/aph.1P482. Epub 2011 Mar 17.

PMID:
21415162
11.

Maternal use of selective serotonin reuptake inhibitors during pregnancy and neonatal bone density.

Dubnov-Raz G, Hemilä H, Vurembrand Y, Kuint J, Maayan-Metzger A.

Early Hum Dev. 2012 Mar;88(3):191-4. doi: 10.1016/j.earlhumdev.2011.08.005. Epub 2011 Sep 3.

PMID:
21890289
12.

Adherence to treatment with selective serotonin reuptake inhibitors and the risk for fractures and bone loss: a population-based cohort study.

Zucker I, Chodick G, Grunhaus L, Raz R, Shalev V.

CNS Drugs. 2012 Jun 1;26(6):537-47. doi: 10.2165/11633300-000000000-00000.

PMID:
22612695
13.

Depression, selective serotonin reuptake inhibitors, and osteoporosis.

Bab I, Yirmiya R.

Curr Osteoporos Rep. 2010 Dec;8(4):185-91. doi: 10.1007/s11914-010-0026-z. Review.

PMID:
20809204
14.

Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarction.

Labos C, Dasgupta K, Nedjar H, Turecki G, Rahme E.

CMAJ. 2011 Nov 8;183(16):1835-43. doi: 10.1503/cmaj.100912. Epub 2011 Sep 26.

15.

Impact of selective serotonin reuptake inhibitor therapy on heart valves in patients exposed to benfluorex: a multicentre study.

Maréchaux S, Jeu A, Jobic Y, Ederhy S, Donal E, Réant P, Abouth S, Arnasteen E, Boulanger J, Ennezat PV, Garban T, Szymanski C, Tribouilloy C.

Arch Cardiovasc Dis. 2013 Jun-Jul;106(6-7):349-56. doi: 10.1016/j.acvd.2013.04.006. Epub 2013 May 31.

16.

A randomised controlled trial of cognitive behaviour therapy in adolescents with major depression treated by selective serotonin reuptake inhibitors. The ADAPT trial.

Goodyer IM, Dubicka B, Wilkinson P, Kelvin R, Roberts C, Byford S, Breen S, Ford C, Barrett B, Leech A, Rothwell J, White L, Harrington R.

Health Technol Assess. 2008 May;12(14):iii-iv, ix-60.

17.

Selective serotonin reuptake inhibitor treatment and risk of fractures: a meta-analysis of cohort and case-control studies.

Wu Q, Bencaz AF, Hentz JG, Crowell MD.

Osteoporos Int. 2012 Jan;23(1):365-75. doi: 10.1007/s00198-011-1778-8. Epub 2011 Sep 9.

PMID:
21904950
18.

A systematic chart review of the nature of psychiatric adverse events in children and adolescents treated with selective serotonin reuptake inhibitors.

Wilens TE, Biederman J, Kwon A, Chase R, Greenberg L, Mick E, Spencer TJ.

J Child Adolesc Psychopharmacol. 2003 Summer;13(2):143-52.

PMID:
12886909
19.

Bone mineral density in adolescents with eating disorders exposed to selective serotonin reuptake inhibitors.

Couturier J, Sy A, Johnson N, Findlay S.

Eat Disord. 2013;21(3):238-48. doi: 10.1080/10640266.2013.779183.

PMID:
23600554
20.

[Selective serotonin reuptake inhibitor and gastrointestinal hemorrhage].

Yamamoto T, Abe K, Kuyama Y.

Nihon Rinsho. 2013 Apr;71(4):751-6. Review. Japanese.

PMID:
23678611
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk